To further evaluate the effect of zebularine-induced ICD on tumor growth inhibition in tumor-bearing immunocompetent mice, we performed single-cell RNA sequencing of CD45- cells in the tumor tissue from tumor-bearing mice after 12 days of zebularine treatments. The gene discussed is PTPRC; the disease is neoplasm.